Entropy Technologies »

Blueprint Medicines shares owned by Entropy Technologies

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $396k 4.3k 92.24

More positions owned by Entropy Technologies

Constellation Brands Cl A (STZ)
Schlumberger Com Stk (SLB)
FactSet Research Systems (FDS)
Marathon Oil Corporation (MRO)
Humana (HUM)
Accenture Plc Ireland Shs Class A (ACN)
Monday SHS (MNDY)
Fox Corp Cl A Com (FOXA)
Zscaler Incorporated (ZS)
M&T Bank Corporation (MTB)
Shift4 Pmts Cl A (FOUR)
Cintas Corporation (CTAS)
ResMed (RMD)
Intel Corporation (INTC)
Advanced Micro Devices (AMD)

View all positions for Entropy Technologies

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines